Supplier · public contract awards
AbbVie Deutschland GmbH & Co. KG public contracts.
AbbVie Deutschland GmbH & Co. KG has won 164 public contracts between 2017 and 2026 from 15 public buyers in Germany. Its most frequent buyer is GWQ ServicePlus AG (25 awards). Outside TED, published values total €3.2 million across 6 awards. 90 awards were published on TED; the median contract size is about €210,000 (6 contracts with a value).
164Contracts won
15Public buyers
1Country
Jul 2026Latest award
Latest contracts won
Németország – Gyógyszerészeti termékek – Vereinbarung nach § 130c SGB V für das Arzneimittel Maviret mit der Wirkstoffkombination Glecaprevir/PibrentaAwarded by AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · Germany
16 Jul 2026Awarded
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dexamethason (auAwarded by DAK-Gesundheit · Germany
16 Jun 2026Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstofffixkombination Glecaprevir und PibreAwarded by AOK Baden-Württemberg · Germany
30 Mar 2026Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026Awarded by Pbmg Eg · Germany
2 Mar 2026Awarded
Németország – Gyógyszerészeti termékek – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bimatoprost + TiAwarded by DAK-Gesundheit · Germany
29 Sep 2025Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025Awarded by Pbmg Eg · Germany
5 May 2025Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025Awarded by Pbmg Eg · Germany
15 Apr 2025Awarded
Németország – Gyógyszerészeti termékek – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V zum Wirkstoff Aquipta (Atogepant)Awarded by GWQ ServicePlus AG · Germany
31 Mar 2025Awarded
Németország – Gyógyszerészeti termékek – Vertragsabschluss zum Arzneimittelwirkstoff Atogepant, Verkaufsname: Aquipta , Unternehmen: AbbVie DeutschlanAwarded by AOK Rheinland/Hamburg - Die Gesundheitskasse · Germany
19 Feb 2025Awarded
Németország – Gyógyszerészeti termékek – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 SGB V / § 130c Absatz 1 SGB V - Aquipta (Wirkstoff: AtoAwarded by DAK-Gesundheit · Germany
19 Feb 2025Awarded
Contracts won by year
Contracts won by year
from the published records20174
20188
20196
20208
20226
20236
202410
20259
20267
Published value, by currency (feeds other than TED)
EUR · 6 valued
€3.2 million
Typical contract size on TED
EUR · median of 6 contracts
€210,000
From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.
Bid with askTender
Bidding against AbbVie Deutschland GmbH & Co. KG?
askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.
Start bidding ↗ See open tenders